Company
United StatesPublic company, NASDAQ: NTRANatera Inc (NASDAQ: NTRA), San Carlos, CA – FDA Inspections
Inspection records and compliance data for Natera Inc in San Carlos, California. 2 FDA inspections on record, last inspected April 10, 2026. Publicly traded as NASDAQ: NTRA.
Company Profile
This profile covers Natera Inc based in San Carlos, California, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected November 8, 2018. Last inspected April 10, 2026.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 10, 2026 | Not classified | Medical Devices & Rad Health | 1307012 |
| November 8, 2018 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 1077867 |
FDA documents
EIRs (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Natera Inc
Stock ticker
NTRA
Exchange
NASDAQ
Share price
$322.94
Market cap
$46.8B
Price as of
November 13, 2026
FEI Number
3010889807
Address
201 Industrial Rd Ste 410, San Carlos, California 94070, United States
Country
United States
ID: fc02a657-83be-4e28-a84e-aa752f3ccf88